For the latter with BC, aromatase inhibitors (AIs) are crucial drugs which dramatically reduce estrogenic levels in the blood by specifically causing the inactivation of aromatase, blocking the aromatization, and inhibiting estrogen formation, so as to achieve the purpose of curing the BC [6]. The gene discussed is CYP19A1; the disease is breast cancer.